Northside Hospital, Inc.
Northside Hospital, Inc.
Explore linked clinical trials.9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Axatilimab + CAR-T for High-Risk Lymphoma | B-cell neoplasm, Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, digestive system disorder, follicular lymphoma, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, pyloric stenosis, stomach disorder | Not yet recruiting | Phase 1 | 2026-06-10 | NCT07638982 | |
| Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease | Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-04-20 | NCT06046248 | |
| CAR T-cell Therapy in Patients With Renal Dysfunction | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-04-20 | NCT05909059 | |
| Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-04-20 | NCT05519579 | |
| Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Recruiting | Phase 2 | 2026-04-20 | NCT02828592 | |
| Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide | Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, hematologic disorder | Recruiting | Phase 2 | 2026-04-16 | NCT06828796 | |
| Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Not stated | 2026-04-16 | NCT05417971 | |
| GM-CSF With Post-Transplant Cyclophosphamide | Transplant-Related Hematologic Malignancy | Recruiting | Phase 2 | 2026-04-16 | NCT04237623 | |
| Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 | 2026-04-06 | NCT07511062 |